EUVIMEDEUVIMED entdecken
Crossref

Role of Epigenetics Variation with Focus on DNA Methylation in Triple-Negative Breast Cancer Patients

G. Deepthi Reddy, V. Brahmaiah, B. Y. Kavitha, Jayalatha Nethagani, Elizabeth Caroline Palaparthi, Rajasekhar Reddy Lebaka, G. Deepika

Archives of Medicine and Health Sciences · 2023-01 · 11 (1) · 96-110

DOI: 10.4103/amhs.amhs_195_22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Medicine and Health Sciences, online erschienen am 26.05.2023. Verfasst von G. Deepthi Reddy und 6 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 198 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is distinguished by the absence of human epidermal growth factor 2 receptors, estrogen, and progesterone. Due to its destructive character and inability to be treated with current endocrine medications, it has one of the worst prognoses of any breast cancer subtype. The only therapies available are chemo-and/or radiation and surgery, which necessitates the development of new biomarkers or therapeutic targets. Due to of their inherent inclination to operate as antisense regulators and interactors of whole gene set implicated in cancer, microRNAs (miRNAs) are a potential target for TNBC-focused therapy. In this paper, we summarize the role of epigenetics variation with a focus on DNA methylation in TNBC patients. Other biomarkers alterations and interactions with miRNAs may lead to the identification of novel therapy options for TNBC in the future as well.

Zitieren

APA

Reddy, G. D., Brahmaiah, V., Kavitha, B. Y., Nethagani, J., Palaparthi, E. C., Lebaka, R. R., & Deepika, G. (2023). Role of Epigenetics Variation with Focus on DNA Methylation in Triple-Negative Breast Cancer Patients. Archives of Medicine and Health Sciences, 11(1), 96-110. https://doi.org/10.4103/amhs.amhs_195_22

Vancouver

Reddy GD, Brahmaiah V, Kavitha BY, Nethagani J, Palaparthi EC, Lebaka RR, et al. Role of Epigenetics Variation with Focus on DNA Methylation in Triple-Negative Breast Cancer Patients. Archives of Medicine and Health Sciences. 2023;11(1):96-110. doi:10.4103/amhs.amhs_195_22

BibTeX
@article{Reddy2023,
  author = {Reddy, G. Deepthi and Brahmaiah, V. and Kavitha, B. Y. and Nethagani, Jayalatha and Palaparthi, Elizabeth Caroline and Lebaka, Rajasekhar Reddy and Deepika, G.},
  title = {Role of Epigenetics Variation with Focus on DNA Methylation in Triple-Negative Breast Cancer Patients},
  journal = {Archives of Medicine and Health Sciences},
  year = {2023},
  volume = {11},
  number = {1},
  pages = {96--110},
  doi = {10.4103/amhs.amhs_195_22}
}
Kostenlos starten →